Resources
Managing Cancer as a Chronic Illness
June 14, 2024 - June is National Cancer Survivor Month, a time dedicated to celebrating and recognizing cancer survivors, inspiring those recently diagnosed, supporting families, and reaching out to communities. According to the latest data from the Centers for Disease Control and Prevention (CDC), more people are living longer after a cancer diagnosis. Currently,…New Gene Tool for Predicting Prostate Cancer Recurrence
April 26, 2024 - A recent research paper published in Oncotarget, a weekly peer-reviewed open access medical journal focusing on all aspects of oncology, reveals that researchers from UR Medicine’s Wilmot Cancer Institute and Roswell Park Cancer Institute have identified a potential new tool for predicting the recurrence of prostate cancer post-surgery based on…Rethinking Metastasis and Early-Stage Tumors
March 11, 2024 - Scientists at The Scripps Research Institute (TSRI) have discovered why some cancers may reoccur after years in remission. The findings, published recently in the journal Cell Reports, show that invasive tumors can begin sending out tumor cells far earlier than previously thought. These escaping cells, which can enter the bloodstream before…Comparing the CyberKnife® and Proton Therapy
February 20, 2024 - Radiation therapy can be classified according to the types of radiation particles or waves that are used to deliver the treatment. The three major types of radiation therapy are photons, electrons, or protons. While all three types have similar effects on tumor tissue and damage cancer cells, photons and electrons…Dr. Heuser's Journey
Discover the inspiring story of Dr. Heuser, a general surgeon, who made the crucial decision to opt for CyberKnife technology in his personal battle against prostate cancer.
Finding Relief from TN Pain
Vernon Traxler endured the agony of trigeminal neuralgia for over 16 years. Discover how the CyberKnife technology brought him lasting relief after just one treatment.
Precision = Superior Results.
The CyberKnife targets tumors with pinpoint accuracy, delivering high-dose radiation directly to the tumor while minimizing damage to healthy tissue, resulting in fewer side effects.